EUVIMEDEUVIMED entdecken
Crossref

Steatotic hepatocellular carcinoma: Association of MRI findings to underlying liver disease and clinicopathological characteristics

Jae Hyon Park iD, Young Nyun Park iD, Myeong-Jin Kim iD, Mi-Suk Park iD, Jin-Young Choi iD, Yong Eun Chung iD, Hyungjin Rhee iD

Liver International · 2023-06 · 43 (6) · 1332-1344

DOI: 10.1111/liv.15589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 23.04.2023. Verfasst von Jae Hyon Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Research Institute of Radiological Science, Center for Clinical Imaging Data Science, Severance Hospital, Yonsei University …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Metabolic Syndrome, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Fatty change is commonly observed in hepatocellular carcinoma (HCC); however, the characteristics of steatotic and steatohepatitic HCCs are not well understood.

Methods

This retrospective study included patients with HCCs who underwent resection between January 2014 and December 2019 to evaluate clinicopathological and magnetic resonance imaging features. Tumours were categorized as magnetic resonance imaging‐steatotic, pathology‐steatotic and steatohepatitic HCCs and were defined as HCCs with ≥50% steatosis on in‐and‐oppose phase images, ≥34% tumour cells with lipid droplets and ≥50% tumour areas with steatohepatitic features on light microscopy respectively.

Results

Of 465 HCCs, 38 (8%), 23 (5%) and 15 (3%) were diagnosed as magnetic resonance imaging‐steatotic, pathology‐steatotic and steatohepatitic HCCs respectively. These HCC variants were less likely to be associated with hepatitis B virus infections than with type 2 diabetes mellitus, metabolic syndrome, non‐tumour liver steatosis and steatohepatitis. Moreover, microvascular invasion was less likely to be associated with them than either tumour size or differentiation. Type 2 diabetes and non‐tumour steatosis were independent risk factors for magnetic resonance imaging‐steatotic HCCs. Pathology‐steatotic HCCs and steatohepatitic HCCs were significantly associated with magnetic resonance imaging‐steatotic HCCs. A targetoid appearance in the transitional or hepatobiliary phase was also more prevalent in steatohepatitic‐HCCs than in non–steatohepatitic‐HCCs. When magnetic resonance imaging‐steatotic HCCs were combined with one or more ancillary features, the sensitivity and specificity were 60% and 97% respectively.

Conclusion

Underlying fatty liver disease and metabolic syndrome are strongly associated with both steatotic and steatohepatitic HCCs. Clinicoradiological characteristics help identify steatohepatitic HCC with high specificity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMetabolic SyndromeDiabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseHumansRetrospective StudiesMagnetic Resonance ImagingSensitivity and SpecificityContrast MediaGadolinium DTPA

Stichwörter der Autor:innen

WHO classificationhepatocellular carcinomahistopathologyliver imaging reporting and data system 2018magnetic resonance imagingmetabolic syndrome

Substanzen

Contrast MediaGadolinium DTPA

Autor:innen und Institutionen

  • Department of Radiology, Research Institute of Radiological Science, Center for Clinical Imaging Data Science, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Department of Pathology, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea.

ORCID-Profile: Jae Hyon Park, Young Nyun Park, Myeong-Jin Kim, Mi-Suk Park, Jin-Young Choi, Yong Eun Chung, Hyungjin Rhee

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Park, J. H., Park, Y. N., Kim, M. J., Park, M. S., Choi, J. Y., Chung, Y. E., & Rhee, H. (2023). Steatotic hepatocellular carcinoma: Association of MRI findings to underlying liver disease and clinicopathological characteristics. Liver International, 43(6), 1332-1344. https://doi.org/10.1111/liv.15589

Vancouver

Park JH, Park YN, Kim MJ, Park MS, Choi JY, Chung YE, et al. Steatotic hepatocellular carcinoma: Association of MRI findings to underlying liver disease and clinicopathological characteristics. Liver International. 2023;43(6):1332-1344. doi:10.1111/liv.15589

BibTeX
@article{Park2023,
  author = {Park, Jae Hyon and Park, Young Nyun and Kim, Myeong-Jin and Park, Mi-Suk and Choi, Jin-Young and Chung, Yong Eun and Rhee, Hyungjin},
  title = {Steatotic hepatocellular carcinoma: Association of MRI findings to underlying liver disease and clinicopathological characteristics},
  journal = {Liver International},
  year = {2023},
  volume = {43},
  number = {6},
  pages = {1332--1344},
  doi = {10.1111/liv.15589}
}
Kostenlos starten →